Abstract
Most of the animal models commonly used for preclinical research into Alzheimer's disease (AD) largely fail to address the pathophysiology, including the impact of known risk factors, of the widely diagnosed sporadic form of the disease. Here, we use a transgenic rat (APP21) that does not develop AD-like pathology spontaneously with age, but does develop pathology following vascular stress. To further the potential of this novel rat model as a much-needed pre-clinical animal model of sporadic AD, we characterize APP21 transgenic rats behaviorally and histologically up to 19 months of age. The open field test was used as a measure of activity; and the Morris water maze was used to assess learning, memory, and strategy shift. Neuronal loss and microglia activation were also assessed throughout the brain. APP21 transgenic rats showed deficits in working memory from an early age, yet memory recall performance after 24 and 72 h was equal to that of wildtype rats and did not deteriorate with age. A deficit in strategy shift was observed at 19 months of age in APP21 transgenic rats compared to Fischer wildtype rats. Histologically, APP21 transgenic rats demonstrated accelerated white matter inflammation compared to wildtype rats, but ...Continue Reading
References
Apr 12, 2000·Behavior Research Methods, Instruments, & Computers : a Journal of the Psychonomic Society, Inc·S DalmM S Oitzl
Aug 15, 2002·Learning & Memory·Morgan D BarenseMark G Baxter
Mar 20, 2003·Synapse·Michael T WilliamsCharles V Vorhees
Oct 15, 2005·Pharmacology·Laurent LecanuVassilios Papadopoulos
Nov 29, 2005·Experimental Neurology·David L Brody, David M Holtzman
Sep 25, 2007·Neurobiology of Aging·J L BizonW H Griffith
Feb 8, 2008·Genes, Brain, and Behavior·O Wirths, T A Bayer
Feb 28, 2008·BMC Neuroscience·Cansu AgcaYuksel Agca
Mar 25, 2008·Behavioural Brain Research·Stan B FlorescoMaric T L Tse
Oct 25, 2011·Journal of Neurochemistry·Rebecca F RosenLary C Walker
Oct 2, 2012·Metabolism: Clinical and Experimental·Theodore B Vanitallie
May 3, 2013·Alzheimer's Research & Therapy·Laurent Lecanu, Vassilios Papadopoulos
Aug 8, 2013·Current Alzheimer Research·Teng JiangLan Tan
Jan 31, 2014·Frontiers in Aging Neuroscience·Michael GuidiThomas C Foster
Sep 5, 2014·Brain Pathology·Hayley Joy NellDavid Floyd Cechetto
Oct 2, 2014·Neuroscience·S ParsiL Dargahi
Feb 17, 2015·Fluids and Barriers of the CNS·Gerald D SilverbergEdward G Stopa
Apr 3, 2015·Molecular Neurobiology·Zi-Xuan WangJin-Tai Yu
Sep 25, 2015·Journal of Alzheimer's Disease : JAD·Michel BilelloChristos Davatzikos
Dec 29, 2015·Brain Research Bulletin·Kristen D OnosMichael Sasner
Feb 19, 2016·Journal of Alzheimer's Disease : JAD·Matthew W GrangerSteffany A L Bennett
Oct 14, 2016·Disease Models & Mechanisms·Bart Ellenbroek, Jiun Youn
Dec 4, 2016·Neurotoxicity Research·Katherine Garcia RavelliLuiz Roberto Britto
Dec 28, 2016·Acta Neuropathologica·Eleanor Drummond, Thomas Wisniewski
Feb 6, 2017·Methods in Molecular Biology·Víctor CarrielStefano Geuna
Citations
Jul 23, 2019·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Vladimir HachinskiZaven S Khachaturian
Dec 8, 2019·GeroScience·Farzaneh A SorondFrank Barone
Sep 30, 2020·EJNMMI Research·Nassir U Al-KhishmanJonathan D Thiessen
Jan 2, 2021·Frontiers in Neuroscience·Smitha Karunakaran
Jun 1, 2021·Journal of Alzheimer's Disease : JAD·Barbara Blicher ThomsenBente Finsen
Oct 6, 2020·Aging and Disease·Chi Him PoonLee Wei Lim
Jul 11, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Nadja Van CampHervé Boutin
Nov 9, 2021·Frontiers in Aging Neuroscience·Bai-Chuang ShyuAndrew Chih Wei Huang